0
ARTICLE |

Sympathomimetics and Schizophrenia FREE

NORRIS HANSELL, MD
JAMA. 1975;234(12):1220-1220. doi:10.1001/jama.1975.03260250012002
Text Size: A A A
Published online

To the Editor.—  Amphetamine psychosis has long been known to mimic schizophrenia.1,2 Some experiences in my practice suggest that limited, continuing use of amphetamine and related substances may exert a deregulating effect on chronic schizophrenia. In particular, it appears that several sympathomimetic materials can yield subtle or dramatic exacerbations in the course of schizophrenia, the origin of which may not be visible without precise inquiry. Of a group of 575 schizophrenics under my care, and all on phenothiazine therapy, 26 are thought to have shown such exacerbations, which abated on stopping simultaneously taking a sympathomimetic material. This number is likely an understatement, because many of the events were not recognized because of our only recent appreciation of this matter. It is not mainly sympathomimetics prescribed by physicians that constitute the bulk of this problem; it is the presence of these materials in over-the-counter pharmaceuticals, particularly in diet pills and

REFERENCES

Snyder SH:  Catecholamines in the brain as mediators of amphetamine psychosis . Arch Gen Psychiatr 27:169-179, 1972;.
Kety SS:  Progress toward understanding the biological substrates of schizophrenia , in Fieve RR et al (eds): Genetic Research in Schizophrenia . Baltimore, Johns Hopkins University Press, 1975;, pp 15-26.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Snyder SH:  Catecholamines in the brain as mediators of amphetamine psychosis . Arch Gen Psychiatr 27:169-179, 1972;.
Kety SS:  Progress toward understanding the biological substrates of schizophrenia , in Fieve RR et al (eds): Genetic Research in Schizophrenia . Baltimore, Johns Hopkins University Press, 1975;, pp 15-26.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.